The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | L | Antineoplastic and immunomodulating agents | |
| 2 | L01 | Antineoplastic agents | |
| 3 | L01D | Cytotoxic antibiotics and related substances | |
| 4 | L01DB | Anthracyclines and related substances | |
| 5 | L01DB02 | Daunorubicin |
| Active Ingredient | Description | |
|---|---|---|
| Daunorubicin |
Daunorubicin is an anthracycline glycoside antibiotic and is a potent antileukaemic agent. It also has immunosuppressant effects. Daunorubicin may involve binding to DNA by intercalation between base pairs and inhibition of DNA and RNA synthesis by template disordering and steric obstruction. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CERUBIDIN Powder for concentrate for solution for infusion | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| DAUNOBLASTIN Powder for solution for injection | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| DAUNOXOME Concentrate for solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
